Dna stock price the dna stock price stands at the

The dna stock price stands at the intersection of biotech optimism and risk-off macro environments, where interest rate trends could influence valuation multiples. Neil Patel has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Amazon and Bitcoin. The Motley Fool recommends Kraft Heinz. The Motley Fool has a disclosure policy . Ginkgo Bioworks Holdings, Inc. (DNA) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. The dna stock price has outperformed small-cap biotech peers over the past month, making it a candidate for momentum-based trading setups.